Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Schroders
21m
IBT's financial year in review
A year of recovery After a challenging period, 2024 has seen a more positive backdrop emerge for the biotechnology sector. In ...
McKnight's Long-Term Care News
1h
Schizophrenia treatment offers alternative with fewer side effects
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Pete Rose dies at 83
NBA Hall of Famer dies
Helene wreaks havoc
‘Ring of fire’ eclipse in Oct
Blocks songs from artists
Illegal cloning sentencing
NYC tunnel shutdown
Lose 'superhero' trademark
Mich. nuclear plant to restart
Line Fire prompts evacuation
Sells stake in DirecTV
Defensive Player of the Year
Sues US Senate committee
Three PFLP leaders killed
Comer subpoenas Mayorkas
Seeks bribery dismissal
'Sing Sing' actor exonerated
$567M Taiwan defense aid
To sue Google, Samsung
Settles data breach cases
Nepal floods: Death toll rises
To lay off 2,900 employees
Ozzie Virgil Sr. dies at 92
Red Sox honor radio voice
SpaceX Falcon 9 grounded
Signals more rate cuts
Israel announces operation
Related topics
Prime Medicine
New York Stock Exchange
Food and Drug Administration
Cobenfy
Celgene
Feedback